Automation News and Research

RSS

Frequently asked questions about BioAFM

Do you have a question about BioAFM? This article will tell you everything you need to know.

From Bruker BioAFM 17 Mar 2025

An innovative approach results in a groundbreaking mobile robot for the pharmaceutical industry

Meet Sterimove, the innovative mobile robot designed for Grade A/B/C/D cleanrooms, optimizing pharmaceutical production while minimizing contamination risks.

From Stäubli 12 Mar 2025

Making Complex Cell Culture Easy and Efficient with AI

Molecular Devices' CellXpress AI streamlines cell culture processes, reducing human error and improving efficiency in drug discovery with advanced automation.

From Molecular Devices UK Ltd 12 Mar 2025

Beckman Coulter Life Sciences and Rarity Bioscience AB Partnership Brings Molecular Research to Flow Cytometry

Innovative superRCA technology from Rarity Bioscience AB enhances flow cytometry, expanding oncology research possibilities and improving mutation detection.

From Beckman Coulter Life Sciences - Flow Cytometry 5 Mar 2025

LabVantage Solutions unveils version 8.9 of its industry-leading LIMS platform to improve lab productivity and efficiency

LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services, today announced the release of LabVantage 8.9, the latest iteration of its flagship laboratory information management system (LIMS), to deliver the most cutting-edge capabilities to laboratories worldwide.

3 Mar 2025

Microphysiological systems in drug discovery

NewsMedical speaks with CN Bio about the translatability between in vitro organ-on-a-chip (OOC) models, microphysiological systems, and their in vivo counterparts.

From CN Bio 26 Feb 2025

Insilico Medicine reaches preclinical milestone in MASH drug discovery

Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, recently achieved preclinical milestone in its collaboration with Therasid Bioscience, a South Korean based biotechnology company focuses on developing innovative first-in-class drugs for treatment for metabolic dysfunction-associated steatohepatitis (MASH).

25 Feb 2025

AI-driven discovery unveils TNIK inhibition as anti-aging strategy

A groundbreaking study led by researchers at Insilico Medicine has revealed the potential of TNIK inhibition as an innovative anti-aging strategy.

22 Feb 2025

Diabetes drugs may boost brain health but experts warn of risks

Researchers reviewed 374 studies to explore how GLP-1RAs, originally for diabetes, may impact brain health, finding potential benefits for dementia and addiction but inconsistent results for mood disorders.

16 Feb 2025

Leveling up NGS workflows with INTEGRA Biosciences’ solutions

INTEGRA Biosciences offers liquid handling solutions and magnetic modules to streamline every stage of NGS sample preparation. These innovative tools help to reduce errors, improve the precision and reliability of sequencing data, and provide more efficient processes.

From INTEGRA Biosciences 14 Feb 2025

Insilico Medicine announces preclinical drug discovery benchmarks from 2021 to 2024

Insilico Medicine ( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced a set of preclinical drug discovery benchmarks from the 22 developmental candidate nominations achieved by its platform from 2021 to 2024.

11 Feb 2025

Breakthrough model simulates human bone marrow function in the lab

Hidden within our bones, marrow sustains life by producing billions of blood cells daily, from oxygen-carrying red cells to immune-boosting white cells.

31 Jan 2025

INTEGRA Biosciences' reagent dispenser now supports SiLA-2 integration

INTEGRA Biosciences’ WELLJET reagent dispenser now supports API commands based on the SiLA-2 standardized communication protocol for lab automation. This new functionality will make it even easier to integrate the WELLJET into automated laboratory workflows, helping labs to enhance their productivity and reproducibility.

30 Jan 2025

Bruker launches infrared imaging microscope for pharma and life science research

Bruker Corporation announced the launch of the LUMOS™ II ILIM , a quantum cascade laser (QCL) based infrared imaging microscope. The new LUMOS II ILIM redefines performance standards, enabling pharma and life science researchers to capture ultrafast IR images of expansive areas with enhanced spatial resolution.

From Bruker Optics 29 Jan 2025

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Tecan, the global leader in laboratory automation, today announced the unveiling of Veya™, a transformative liquid handling platform designed to bring efficiency, precision and compliance to laboratories of all sizes.

29 Jan 2025

Trilobio introduces whole-laboratory automation platform at SLAS2025

Trilobio, developer of whole lab automation solutions for advancing biology research, today introduced the first version of its comprehensive robotics, lab equipment and software platform at the Society for Laboratory Automation and Screening conference, SLAS2025, alongside pilot customer data, demonstrating the platform's abilities in advancing research workflows.

From Trilobio 28 Jan 2025

Sphere Fluidics launches Cyto-Mine Chroma and announces Early Access Program

Sphere Fluidics, a leading provider of innovative picodroplet-based microfluidics solutions for functional single cell analysis and isolation, today announced the launch of Cyto-Mine® Chroma and the opening of its Early Access Program at SLAS2025 International Conference and Exhibition in San Diego.

27 Jan 2025

New approach uses peptides to enhance anti-tumor drug formulations

A team of scientists has developed a groundbreaking approach using specially designed peptides to improve drug formulations.

24 Jan 2025

Revvity ignites scientific breakthroughs at SLAS2025

Revvity, Inc. is set to unveil its groundbreaking new Phenologic.AI™ software at SLAS2025 in San Diego, January 27-29. Designed to redefine cellular imaging workflows for Revvity’s Harmony™ and Signals Image Artist™ software packages, the Phenologic.AI software leverages pre-trained deep-learning models to analyze brightfield images, providing an additional multiplexing channel and streamlined workflows for live cell analysis.

From Revvity 24 Jan 2025

New AI software could speed up drug development

The discovery and development of drugs in pharmacological research – including the risk assessment of active substances in the early phase of drug development – still largely relies on animal experiments.

23 Jan 2025